My research journey in pharmacogenomics is driven by the desire to contribute to personalized medicine and enhance patient care. In the context of psychiatric pharmacogenomics, understanding genetic variations can help predict individual responses to psychotropic medications, enabling personalized treatment plans and eliminating the “trial and error” phase during dose optimization. I would like to address the challenges that lie ahead for pharmacogenomics, with a specific interest in psychiatric pharmacogenomics.
My research journey in pharmacogenomics is driven by the desire to contribute to personalized medicine and enhance patient care. In the context of psychiatric pharmacogenomics, understanding genetic variations can help predict individual responses to psychotropic medications, enabling personalized treatment plans and eliminating the “trial and error” phase during dose optimization. I would like to address the challenges that lie ahead for pharmacogenomics, with a specific interest in psychiatric pharmacogenomics.